The list includes spinouts aiming to tackle arthritis, cognitive disabilities and diseases of citrus plants.

Faculty and students have been given access to an array of production services at the facility.

The cancer treatment developer spun out from UCL has secured $80m in series C capital from investors including Woodford Investment Management and Syncona.

IdeaRefinery, which will not invest directly in the startups but will provide support, office space and executive mentorship, is supported by National University of Singapore.

The cardiovascular software developer has built modelling programs that could help doctors decide whether patients are fit for surgery.

University of Pittsburgh and accelerator BioMotiv are set to generate a spinout based on anti-inflammatory research by Rama Mallampalli and Beibei Chen.

Vertera Spine, a spinal implant developer base on Duke and Georgia Tech research, has been picked up shortly after receiving regulatory approval for two products.